V Mave1, S Meshram4, R Lokhande2, D Kadam2, S Dharmshale2, R Bharadwaj2, A Kagal2, N Pradhan3, S Deshmukh3, S Atre4, T Sahasrabudhe4, M Barthwal4, S Meshram4, A Kakrani4, V Kulkarni3, S Raskar3, N Suryavanshi3, R Shivakoti5, S Chon5, E Selvin6, A Gupte6, A Gupta1, N Gupte1, J E Golub7. 1. Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 2. Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India; Byramjee-Jeejeebhoy Government Medical College, Pune, India. 3. Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India. 4. Dr D Y Patil Medical College, Pune, India. 5. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 6. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 7. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Abstract
SETTING: Pune, India. OBJECTIVES: To estimate the prevalence and risk factors of pre-diabetes mellitus (DM) and DM, and its associations with the clinical presentation of tuberculosis (TB). DESIGN: Screening for DM was conducted among adults (age 18 years) with confirmed TB between December 2013 and January 2017. We used multinomial regression to evaluate the risk factors for pre-DM (glycated hemoglobin [HbA1c] 5.7-6.5% or fasting glucose 100-125 mg/dl) and DM (HbA1c 6.5% or fasting glucose 126 mg/dl or random blood glucose > 200 mg/dl or self-reported DM history/treatment) and the association of dysglycemia with the severity of TB disease. RESULTS: Among 1793 participants screened, 890 (50%) had microbiologically confirmed TB. Of these, 33% had pre-DM and 18% had DM; 41% were newly diagnosed. The median HbA1c level among newly diagnosed DM was 7.0% vs. 10.3% among known DM (P < 0.001). DM (adjusted OR [aOR] 4.94, 95%CI 2.33-10.48) and each per cent increase in HbA1c (aOR 1.42, 95%CI 1.01-2.01) was associated with >1+ smear grade or 9 days to TB detection. CONCLUSION: Over half of newly diagnosed TB patients had DM or pre-DM. DM and increasing dysglycemia was associated with higher bacterial burden at TB diagnosis, potentially indicating a higher risk of TB transmission to close contacts.
SETTING: Pune, India. OBJECTIVES: To estimate the prevalence and risk factors of pre-diabetes mellitus (DM) and DM, and its associations with the clinical presentation of tuberculosis (TB). DESIGN: Screening for DM was conducted among adults (age 18 years) with confirmed TB between December 2013 and January 2017. We used multinomial regression to evaluate the risk factors for pre-DM (glycated hemoglobin [HbA1c] 5.7-6.5% or fasting glucose 100-125 mg/dl) and DM (HbA1c 6.5% or fasting glucose 126 mg/dl or random blood glucose > 200 mg/dl or self-reported DM history/treatment) and the association of dysglycemia with the severity of TB disease. RESULTS: Among 1793 participants screened, 890 (50%) had microbiologically confirmed TB. Of these, 33% had pre-DM and 18% had DM; 41% were newly diagnosed. The median HbA1c level among newly diagnosed DM was 7.0% vs. 10.3% among known DM (P < 0.001). DM (adjusted OR [aOR] 4.94, 95%CI 2.33-10.48) and each per cent increase in HbA1c (aOR 1.42, 95%CI 1.01-2.01) was associated with >1+ smear grade or 9 days to TB detection. CONCLUSION: Over half of newly diagnosed TB patients had DM or pre-DM. DM and increasing dysglycemia was associated with higher bacterial burden at TB diagnosis, potentially indicating a higher risk of TB transmission to close contacts.
Authors: Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu Journal: Immunology Date: 2015-04 Impact factor: 7.397
Authors: R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan Journal: Diabetologia Date: 2011-09-30 Impact factor: 10.122
Authors: P Dave; A Shah; M Chauhan; A M V Kumar; A D Harries; S Malhotra; K Pujara; P Patel; M Mane; A Thakkar; S Bharaswadkar; B N Sharath; S Achanta Journal: Public Health Action Date: 2013-11-04
Authors: Rovina Ruslami; Rob E Aarnoutse; Bachti Alisjahbana; Andre J A M van der Ven; Reinout van Crevel Journal: Trop Med Int Health Date: 2010-11 Impact factor: 2.622
Authors: Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez Journal: Curr Diab Rep Date: 2018-08-09 Impact factor: 4.810
Authors: María B Arriaga; Michael S Rocha; Betânia M F Nogueira; Vanessa Nascimento; Mariana Araújo-Pereira; Alexandra B Souza; Alice M S Andrade; Alysson G Costa; Adriano Gomes-Silva; Elisangela C Silva; Marina C Figueiredo; Megan M Turner; Betina Durovni; José R Lapa-E-Silva; Afrânio L Kritski; Solange Cavalcante; Valeria C Rolla; Marcelo Cordeiro-Santos; Timothy R Sterling; Bruno B Andrade Journal: J Infect Dis Date: 2021-12-15 Impact factor: 5.226
Authors: Clare Eckold; Vinod Kumar; January Weiner; Bachti Alisjahbana; Anca-Lelia Riza; Katharina Ronacher; Jorge Coronel; Sarah Kerry-Barnard; Stephanus T Malherbe; Leanie Kleynhans; Kim Stanley; Rovina Ruslami; Mihai Ioana; Cesar Ugarte-Gil; Gerhard Walzl; Reinout van Crevel; Cisca Wijmenga; Julia A Critchley; Hazel M Dockrell; Jacqueline M Cliff Journal: Clin Infect Dis Date: 2021-01-23 Impact factor: 9.079